SCHEMBL7418486

SCHEMBL7418486

O=C(CC(NS(=O)(=O)c1ccc(Br)cc1)c1ccccc1)NO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
ALDH1A1 P00352 1/20 0.57
EEF2K O00418 3/20 0.56
MMP2 P08253 10/20 0.50
MMP9 P14780 7/20 0.50
MMP3 P08254 6/20 0.50
MMP1 P03956 6/20 0.50
MMP13 P45452 6/20 0.50
MMP7 P09237 5/20 0.50
KMT2A Q03164 1/20 0.48
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
EGFR P00533 1/20 0.47
ERBB2 P04626 1/20 0.47
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2454202 0.89 MMP9 (0.58) ATML3MBTL1ALDH1A1EEF2KMMP2
SCHEMBL7410702 0.85 PDE4A (0.67) ATML3MBTL1ALDH1A1EEF2KMMP2
SCHEMBL3199799 0.83 ALDH1A1 (0.52) ATML3MBTL1ALDH1A1EEF2KMMP2
SCHEMBL7419745 0.81 MMP1 (0.59) ATML3MBTL1ALDH1A1EEF2KMMP2
SCHEMBL28404274 0.78 ATM (0.76) ATML3MBTL1ALDH1A1EEF2KKMT2A
SCHEMBL7473660 0.77 SLC1A3 (0.55) MMP2MMP9MMP3MMP1MMP13
SCHEMBL7418100 0.77 MMP2 (0.55) ALDH1A1MMP2MMP9MMP3MMP1
SCHEMBL14242038 0.75 EGFR (0.51) ATML3MBTL1ALDH1A1EEF2KKMT2A
SCHEMBL14242036 0.75 EGFR (0.51) ATML3MBTL1ALDH1A1EEF2KKMT2A
SCHEMBL7572130 0.75 ATM (0.76) ATML3MBTL1ALDH1A1EEF2KKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed